Vir Biotechnology, Inc. (VIR)

9.12 -0.15 (-1.62%) USD  |  NASDAQ  |  May 08, 16:00
9.12 0.00 (0.00%) After-Hours: 20:00
More

Vir Biotechnology Total Long Term Assets (Quarterly)

Total Long Term Assets (Quarterly) Chart

View Total Long Term Assets (Quarterly) for VIR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Long Term Assets (Quarterly) Range, Past 5 Years

View Total Long Term Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Assets (Quarterly) Benchmarks

View Total Long Term Assets (Quarterly) Benchmarks
Start Trial
Alnylam Pharmaceuticals, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade
Krystal Biotech, Inc. Upgrade
Gossamer Bio, Inc. Upgrade
Sensei Biotherapeutics, Inc. Upgrade